Amber Phelps
Adult Health · Eldersburg, MDNPI 1639760382
Payments from drug & device makers
Across 118 payments — averaging $19.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$314
- Lilly USA, LLC$287
- Lundbeck LLC$250
- Pfizer$179
- Amgen$153
- Bausch Health US, LLC$147
- plus $987 from 20 others
What the payments were for
- Food & beverage$2,317100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 17 | $314 |
| Lilly USA, LLC | 15 | $287 |
| Lundbeck LLC | 13 | $250 |
| Pfizer | 9 | $179 |
| Amgen | 8 | $153 |
| Bausch Health US, LLC | 8 | $147 |
| Exact Sciences | 5 | $139 |
| AstraZeneca | 6 | $122 |
| Corium, LLC | 6 | $119 |
| Boehringer Ingelheim | 5 | $101 |
| AbbVie | 5 | $91 |
| Axsome Therapeutics, Inc. | 3 | $58 |
| Corcept Therapeutics | 2 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $32 |
| Paratek Pharmaceuticals, Inc. | 1 | $30 |
| Seqirus USA Inc | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Merck | 1 | $26 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Dexcom, Inc. | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Bayer | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $17 |
| GSK | 1 | $17 |
| Resmed Corp | 1 | $15 |
How this compares
$2,317 in reported general payments places this provider in the 80th percentile of 542 adult health providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc | 11 | $1,077 |
| Atorvastatin Calcium | 74 | $1,001 |
| Levothyroxine Sodium | 73 | $780 |
| Losartan Potassium | 71 | $692 |
| Montelukast Sodium | 23 | $469 |
| Amlodipine Besylate | 53 | $450 |
| Gabapentin | 21 | $377 |
| Omeprazole | 30 | $358 |
| Rosuvastatin Calcium | 26 | $354 |
| Escitalopram Oxalate | 20 | $326 |
| Sertraline Hcl | 31 | $266 |
| Lisinopril | 29 | $265 |
| Celecoxib | 12 | $262 |
| Pravastatin Sodium | 16 | $255 |
| Pantoprazole Sodium | 23 | $247 |
Paid to pharmacies, not to this prescriber.
Other adult health in Eldersburg
- Lucia NovakCamp Springs$473K
- Caroline RuhlAnnapolis$315K
- Joyce MiskovicHighland$264K
- Christopher RobersonBaltimore$180K
- Amit DhirBaltimore$97K
- Angie PriceBaltimore$96K
- Morgan JoliatSykesville$92K
- Brendon BowerBaltimore$64K
- Caitlin NassBaltimore$46K
- Jane KapustinClarksville$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.